Brainsway Ltd. (BWAY)
Stock Price:
$6.20 USD
0.18 (2.99%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
68.98M |
| Revenue (ttm) |
23.10M |
| Net Income (ttm) |
-10.33M |
| Shares Out |
11.13M |
| EPS (ttm) |
-0.80 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$6.20 |
| Previous Close |
$6.02 |
| Change ($) |
0.18 |
| Change (%) |
2.99% |
| Day's Open |
6.21 |
| Day's Range |
6.06 - 6.21 |
| Day's Volume |
1,641 |
| 52-Week Range |
5.10 - 12.53 |
More Stats
| Market Cap |
68.98M |
| Enterprise Value |
47.08M |
| Earnings Date (est) |
Nov 23, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
11.13M |
| Float |
n/a |
| EPS (basic) |
-1.00 |
| EPS (diluted) |
-0.80 |
| FCF / Share |
-0.98 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
34,580 |
| Short Ratio |
3.09 |
| Short % of Float |
n/a |
| Beta |
0.62 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
2.99 |
| PB Ratio |
3.24 |
| Revenue |
23.10M |
| Operating Income |
-8.48M |
| Net Income |
-10.33M |
| Free Cash Flow |
-10.56M |
| Net Cash |
21.90M |
| Net Cash / Share |
1.97 |
| Gross Margin |
90.39% |
| Operating Margin |
-36.69% |
| Profit Margin |
-44.70% |
| FCF Margin |
-45.69% |
| ROA |
-10.82% |
| ROE |
-36.40% |
| ROIC |
-87.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
3 |
| Overweight |
1 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$11.01*
(77.58% upside)
Low
9.00
Current: $6.20
High
13.00
Target: 11.01
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | 23.10 | 16.40 | 11.15 |
| Revenue Growth | 40.89% | 47.12% | - |
| Gross Profit | 17.97 | 12.81 | 8.55 |
| Operating Income | -8.48 | -5.11 | -6.61 |
| Net Income | -10.33 | -6.48 | -7.05 |
| Shares Outstanding | 21.64 | 21.64 | - |
| Earnings Per Share | -1.00 | -0.78 | -0.96 |
| Operating Cash Flow | -7.24 | -3.77 | -3.47 |
| Capital Expenditures | -3.31 | -1.97 | -0.99 |
| Free Cash Flow | -10.56 | -5.75 | -4.45 |
| Cash & Equivalents | 21.90 | 9.07 | 14.56 |
| Total Debt | - | 2.83 | 2.73 |
| Net Cash / Debt | 21.90 | 6.24 | 11.83 |
| Assets | 38.74 | 23.60 | 27.03 |
| Liabilities | 14.52 | 16.65 | 14.31 |
| Book Value | 24.22 | 6.95 | 12.72 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Brainsway Ltd. |
| Country |
Israel |
| Employees |
107 |
| CEO |
Christopher von Jako |
Stock Information
| Ticker Symbol |
BWAY |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: BWAY |
| IPO Date |
April 17, 2019 |
Description
Brainsway, a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.